Volatility Stories
Is it time to hedge Uipath (USA Stocks:PATH) volatility
 | 3 days ago at Macroaxis By Aina Ster |
UiPath Inc (NYSE: PATH), a key player in the software - infrastructure industry, has exhibited a notable level of volatility, with a standard deviation of 3.25, suggesting significant price swings that can present both risks and opportunities for investors. With a high price of $20.10 and a recent price percent change of 4.69%, the stock has shown the capacity for rapid movements, which can be leveraged by those who employ strategic hedging techniques. The Value At Risk (VaR) of -3.98 indicates the potential for considerable downside, which underscores the importance of using options or other derivatives to mitigate potential losses. Continue Reading...
- PATH Uipath Inc
- Latest UiPaths stock heads for its best day yet as companys AI prowess ... - Morningstar
- PATH 25.04 5.28
- Low 22.13
- High 25.47
- Alpha 0.77
- Beta 3.02
- Return On Equity -0.0793
- Return On Asset -0.0498
- Profit Margin (0.13) %
- Operating Margin (0.17) %
- Current Valuation 12.43 B
- Shares Outstanding 484.28 M
- Shares Owned By Insiders 10.21 %
- Shares Owned By Institutions 63.75 %
- Number Of Shares Shorted 37.52 M
- Price To Earning (1.36) X
- Price To Book 7.24 X
- Price To Sales 11.71 X
- Revenue 1.06 B
- Gross Profit 879.96 M
- EBITDA (317.88 M)
- Net Income (328.35 M)
- Cash And Equivalents 1.72 B
- Cash Per Share 3.13 X
- Total Debt 63.44 M
- Debt To Equity 0.026 %
- Current Ratio 4.58 X
- Book Value Per Share 3.46 X
- Cash Flow From Operations (9.98 M)
- Short Ratio 6.41 X
- Earnings Per Share (0.27) X
- Price To Earnings To Growth 1.39 X
- Target Price 19.6
- Number Of Employees 3.83 K
- Beta 0.59
- Market Capitalization 14.19 B
- Total Asset 2.74 B
- Retained Earnings (1.82 B)
- Working Capital 1.72 B
- Current Asset 23.02 M
- Current Liabilities 3.17 M
- Net Asset 2.74 B
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Gabriel Shpitalnik
In the world of biotechnology stocks, volatility is the name of the game. Axcella Health (AXLA), a prominent player in the industry, is currently experiencing a surge in its stock price, which could potentially signal real growth opportunities. With a Day Typical Price of $4.73 and a Possible Upside Price of 43.9, the company's current market dynamics present an intriguing scenario for investors.
| over two weeks ago at Macroaxis By Gabriel Shpitalnik |  |
Every cloud has a silver lining, and Intrusion Inc., a Software - Infrastructure company traded on NASDAQ, might just be that silver lining for savvy investors this December. Despite the company's current valuation market value standing at a modest $0.48, the possible upside price is a whopping $10.92, presenting a potentially lucrative opportunity. However, investors should tread carefully as the possible downside price is a mere $0.0048.
| over two weeks ago at Macroaxis By Raphi Shpitalnik |  |
LianBio ADR currently holds $4.34 million in liabilities, with a Debt to Equity (D/E) ratio of 0.02. This suggests that LianBio ADR may not be leveraging debt effectively. The company's current ratio stands at 15.49, indicating that it has sufficient liquidity to meet its financial obligations when they are due.
| over a month ago at Macroaxis By Vlad Skutelnik |  |
Despite a modest market downturn, ESSA Pharma, a prominent player in the Biotechnology sector of the Healthcare industry, saw its stock surge over 10% on the NASDAQ exchange. This volatility comes as a surprise given the company's current fiscal year-end estimated loss of $0.69 per share and a projected loss of $1 per share for the next year. However, analysts remain optimistic, with four strong buy recommendations and an overall consensus rating of 'Strong Buy'.
| over a month ago at Macroaxis By Vlad Skutelnik | |
Regions Financial, a leading player in the Banks - Regional industry, has been experiencing significant volatility in recent times. The company, with a Valuation Market Value of 14.44, has seen its stock fluctuate between a Posible Downside Price of 14.57 and a Posible Upside Price of 18.11. This volatility, coupled with a negative Daily Balance Of Power of -1.81 and a Price Action Indicator of -0.97, suggests a bearish market sentiment.
| over a month ago at Macroaxis By Vlad Skutelnik | |
US Bancorp has approximately $44.38 billion in cash, with a positive cash flow from operations of $21.12 billion. This results in a cash-per-share (CPS) ratio of 29.87.
Rigorous look on USB
US Bancorp (USB) has demonstrated a significant level of volatility, with a coefficient of variation of 7.6K, indicating a high degree of risk relative to its expected return. Its total risk alpha of 0.1394 further underscores this inherent risk, suggesting that the stock may not offer sufficient returns to compensate for its risk level.| over a month ago at Macroaxis By Ellen Johnson |  |
Karooooo (NASDAQ: KARO), a prominent player in the software service industry, has been experiencing a decline in volatility, which is expected to continue into November. This trend could potentially present a lucrative investment opportunity. The company, with a market valuation of $21.89 billion, has a real value of $25.75 billion, indicating a potential upside.
| over a month ago at Macroaxis By Vlad Skutelnik | |
In the ever-evolving world of the auto manufacturing industry, Arrival Vault USA, a prominent player in the consumer cyclical category, has recently been experiencing a notable decline in market volatility. With a current market value of 1.19 and a real value of 1.14, this NASDAQ-listed company is presenting a potential investment opportunity that is hard to ignore. The company's valuation hype value stands at 1.11, indicating a relatively stable market sentiment despite the ongoing fluctuations in the broader market.
| over two months ago at Macroaxis By Aina Ster | |
MCloud Technologies Corp currently has approximately $4.41 million in cash, with a positive cash flow from operations of $28.33 million. This results in a cash-per-share (CPS) ratio of 0.27. The company has a Beta (Market Risk) of 1.1493, indicating a somewhat significant risk relative to the market.
| over two months ago at Macroaxis By Ellen Johnson | |